PMC:7321036 / 51037-51268
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T256 | 90-98 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T257 | 101-110 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T19979 | 24-28 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T28590 | 151-156 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T71374 | 227-229 | Chemical | denotes | S8 | http://purl.obolibrary.org/obo/CHEBI_29385 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1127 | 90-110 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T337 | 0-231 | Sentence | denotes | Kinases represent ideal drug targets; here, we identified kinases and pathways altered by SARS-CoV-2 infection that can be targeted by 87 FDA-approved drugs and compounds in clinical trials or in preclinical development (Table S8). |